The PharmacOdynaMic effects of cangrelor in PatiEnts wIth acute or chronIc coronary syndrome undergoing percutaneous coronary intervention (POMPEII) registry (ClincalTrials.gov: NCT04790032) is a prospective study conducted at Federico II University of Naples enrolling all patients undergoing PCI with cangrelor. Pharmacodynamic data show that cangrelor might be a useful option for a fast platelet inhibition during complex PCI, but caution should be paid to a potential rebound effect at the end of its infusion while the oral P2Y12 effect is not yet achieved.
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry
Stabile, Eugenio;Esposito, Giovanni
2023-01-01
Abstract
The PharmacOdynaMic effects of cangrelor in PatiEnts wIth acute or chronIc coronary syndrome undergoing percutaneous coronary intervention (POMPEII) registry (ClincalTrials.gov: NCT04790032) is a prospective study conducted at Federico II University of Naples enrolling all patients undergoing PCI with cangrelor. Pharmacodynamic data show that cangrelor might be a useful option for a fast platelet inhibition during complex PCI, but caution should be paid to a potential rebound effect at the end of its infusion while the oral P2Y12 effect is not yet achieved.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
EIJ-D-22-00594_Gargiulo Pompei.pdf
accesso aperto
Licenza:
Dominio pubblico
Dimensione
558.71 kB
Formato
Adobe PDF
|
558.71 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.